Tempus / tempus.com
AI-powered precision medicine platform analysing molecular and clinical data to personalise cancer treatment decisions, accelerate drug discovery, and match patients to clinical trials.
Pricing
Free
Free plan
No
Category
Developer Tools
Platforms
2
Free plan
No
API access
No
Open source
No
Platforms
2
Tempus is a data-driven oncology and precision medicine company with one of the largest libraries of clinical and molecular data, applying AI to help oncologists make more informed treatment decisions and help pharmaceutical companies identify patients for clinical trials. For oncologists, the AI platform analyses a patient's genomic sequencing results against a large database of similar patients to provide insights into which treatments have been associated with better outcomes in comparable cases. For pharmaceutical companies, Tempus's data platform identifies patients whose genomic and clinical profiles match clinical trial eligibility criteria, reducing patient recruitment time and cost. Tempus went public on NASDAQ (TEM) in 2024, reflecting its position as a significant player in AI-enabled precision medicine.
Tempus AI runs as ml platform software built around data and text workflows. Users typically start with a prompt, upload, or connected data source, and the underlying model handles the heavy lifting before returning a result you can refine or export. It's available on web and api.
Recent YouTube videos cached from the backend so this page stays fast and fresh.
The capabilities that matter most for teams evaluating Tempus AI.
Analyses RNA and DNA sequencing results against a large clinical database to surface treatment-relevant genomic insights for oncologists.
Identifies patients whose genomic and clinical profiles match clinical trial eligibility criteria, reducing pharmaceutical patient recruitment time.
Integrates clinical outcomes across patients in Tempus's database to provide comparative insights on treatment approaches.
Enterprise licensing to health systems, pharmaceutical companies, and research institutions. No public pricing.
Model
Enterprise
Starting price
Free
Free trial
No
Foundation Medicine (Roche subsidiary) provides comparable genomic profiling. Flatiron Health (also Roche) provides oncology real-world data. IBM Watson for Oncology was a notable predecessor that faced clinical validation challenges.
A side-by-side look at the closest alternative in this category.
Key facts about model providers, platforms, and team support.
Model Provider
Tempus
Platforms
Web, API
Deployment
Enterprise
Integrations
EHR integrations, Pharmaceutical platforms, Research systems, API
Team Collaboration
Yes
Launch Year
2015
Compliance signals and data-handling notes as reported by the vendor.
HIPAA compliant. SOC 2 Type II. ISO 27001. Patient genomic and clinical data handled under HIPAA protections with appropriate de-identification for research use.
Patient genomic and clinical data processed under HIPAA protections. Research use data is de-identified per HIPAA standards. Enterprise includes comprehensive data handling agreements.
Editorial Verdict
Tempus is the leading AI precision medicine platform for oncology, most relevant to major cancer centres, health systems with oncology programmes, and pharmaceutical companies for drug discovery and trial matching.
Last verified July 24, 2026.
Enterprise licensing to health systems, pharmaceutical companies, and research institutions. No public pricing.
No publicly listed pricing. Contact Nabla for health system and individual clinician pricing. Limited free trial may be available.
HIPAA compliant. SOC 2 Type II. ISO 27001. Patient genomic and clinical data handled under HIPAA protections with appropriate de-identification for research use.
HIPAA compliant with BAA provided. SOC 2 compliant. Medical data processing under healthcare-appropriate security controls.
Patient genomic and clinical data processed under HIPAA protections. Research use data is de-identified per HIPAA standards. Enterprise includes comprehensive data handling agreements.
Nabla provides HIPAA Business Associate Agreements. Review data handling specifics for each health system deployment. Clinical conversations processed on Nabla's HIPAA-compliant infrastructure.
Verified reviews from signed-in users, stored in the backend and averaged into this tool's rating.
Sign in to rate Tempus AI and leave a review.
No other reviews yet — be the first to share how this tool performs in practice.
